Genertec Universal Medical Group Company Limited (5UM) - Total Assets
Based on the latest financial reports, Genertec Universal Medical Group Company Limited (5UM) holds total assets worth €84.32 Billion EUR (≈ $98.58 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Genertec Universal Medical Group Company (5UM) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Genertec Universal Medical Group Company Limited - Total Assets Trend (2016–2025)
This chart illustrates how Genertec Universal Medical Group Company Limited's total assets have evolved over time, based on quarterly financial data. Check earnings quality score of Genertec Universal Medical Group Company to evaluate the quality of earnings relative to operating cash generation.
Genertec Universal Medical Group Company Limited - Asset Composition Analysis
Current Asset Composition (December 2025)
Genertec Universal Medical Group Company Limited's total assets of €84.32 Billion consist of 42.6% current assets and 57.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 2.5% |
| Accounts Receivable | €31.40 Billion | 37.2% |
| Inventory | €931.06 Million | 1.1% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €284.11 Million | 0.3% |
| Goodwill | €384.30 Million | 0.5% |
Asset Composition Trend (2016–2025)
This chart illustrates how Genertec Universal Medical Group Company Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Genertec Universal Medical Group Company market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Genertec Universal Medical Group Company Limited's current assets represent 42.6% of total assets in 2025, a decrease from 99.2% in 2016.
- Cash Position: Cash and equivalents constituted 2.5% of total assets in 2025, down from 4.4% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 37.2% of total assets.
Genertec Universal Medical Group Company Limited Competitors by Total Assets
Key competitors of Genertec Universal Medical Group Company Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Vardhman Holdings Limited
NSE:VHL
|
India | Rs37.69 Billion |
|
Five-Star Business Finance Limited
NSE:FIVESTAR
|
India | Rs154.35 Billion |
|
Capri Global Capital Limited
NSE:CGCL
|
India | Rs326.76 Billion |
|
Srisawad Power 1979 PCL
BK:SAWAD
|
Thailand | ฿107.67 Billion |
|
Navient Corp
NASDAQ:NAVI
|
USA | $48.68 Billion |
|
Propel Holdings Inc
TO:PRL
|
Canada | CA$639.53 Million |
|
Menif Financial Services Ltd
TA:MNIF
|
Israel | ILA3.82 Billion |
|
General Accident PLC
LSE:GACA
|
UK | GBX14.16 Billion |
Genertec Universal Medical Group Company Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.37 | 1.16 | 2.46 |
| Quick Ratio | 1.33 | 1.14 | 2.45 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €9.64 Billion | €4.46 Billion | €34.05 Billion |
Genertec Universal Medical Group Company Limited - Advanced Valuation Insights
This section examines the relationship between Genertec Universal Medical Group Company Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.50 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -2.0% |
| Total Assets | €84.32 Billion |
| Market Capitalization | $1.24 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Genertec Universal Medical Group Company Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Genertec Universal Medical Group Company Limited's assets decreased by 2.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Genertec Universal Medical Group Company Limited (2016–2025)
The table below shows the annual total assets of Genertec Universal Medical Group Company Limited from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €84.32 Billion ≈ $98.58 Billion |
-1.99% |
| 2024-12-31 | €86.03 Billion ≈ $100.58 Billion |
+7.08% |
| 2023-12-31 | €80.34 Billion ≈ $93.93 Billion |
+4.52% |
| 2022-12-31 | €76.87 Billion ≈ $89.87 Billion |
+9.97% |
| 2021-12-31 | €69.90 Billion ≈ $81.72 Billion |
+13.64% |
| 2020-12-31 | €61.51 Billion ≈ $71.91 Billion |
+6.32% |
| 2019-12-31 | €57.85 Billion ≈ $67.64 Billion |
+22.42% |
| 2018-12-31 | €47.26 Billion ≈ $55.25 Billion |
+25.24% |
| 2017-12-31 | €37.73 Billion ≈ $44.11 Billion |
+30.27% |
| 2016-12-31 | €28.96 Billion ≈ $33.86 Billion |
-- |
About Genertec Universal Medical Group Company Limited
Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the People's Republic of China. It operates through two segments, Finance Business and Healthcare Business. The Finance Business segment offers direct finance leasing; sale and leaseback; accounts receivable factoring; operating leases; and advisory services. Its… Read more